Indexed with PubMed and Science Citation Index (E) 
Users online: 5381 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
    Next article
    Previous article
    Table of Contents

    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal


Year : 1995  |  Volume : 61  |  Issue : 3  |  Page : 137--139

A comparative study of loratadine versus pheniramine maleate in chronic idiopathic urticaria

Department of Skin and STD, BJ Medical College and Civil Hospital, Asharwa, Ahmedabad-380016, India

Correspondence Address:
Ranjan C Raval
100-A, Keshav Nagar, Nr. Subhas Bridge; Sabarmati, Ahmedabad-380027
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 20952926

Rights and PermissionsRights and Permissions

Fifty cases with chronic idiopathic urticaria of more than 3 months duration were selected and divided into two groups. Group ΆA' was given 10 mg loratadine once daily, while group ‘B’ was given pheniramine maleate 25 mg, twice daily for one month. All patients were followed for one month more. 48% excellent response was observed in group ‘A’ while 16% excellent response was observed in group ‘B’. Good response was observed in 24% of patients in group ‘A’, while in group ‘B’ 16% of patients had good response. No side effects were observed in Ioratadine group, while drowsiness was observed in pheniramine group.

[PDF Not available]*

Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow